New features, new look and now mobile-responsive! No need to re-register.
Logo

Get Healthy!

Results for search "Cancer: Leukemia".

Health News Results - 17

WEDNESDAY, March 27, 2019 (HealthDay News) -- The chances of finding an unrelated bone marrow donor are higher for U.S. patients of European descent than for those of non-European descent, a new study finds.

A bone marrow transplant can sometimes help people with life-threatening blood cancers by replacing the patient's cells with healthy ones from a donor. A brother or sister with th...

WEDNESDAY, Feb. 6, 2019 (HealthDay News) -- All expectant parents worry, and for those undergoing fertility treatments, there are additional concerns about the health of their child.

But a new study finds one less thing they need to stress over -- their children don't appear to be at greater risk of cancer than other children.

"These results provide reassuring evidence that ...

WEDNESDAY, Aug. 22, 2018 (HealthDay News) -- Poverty is a major reason black and Hispanic children with some types of cancer have lower survival rates than white patients, a new study finds.

Researchers examined U.S. government data on nearly 32,000 black, Hispanic and white children who were diagnosed with cancer between 2000 and 2011. For several cancers, whites were much more likel...

FRIDAY, July 20, 2018 (HealthDay News) -- The increased risk of cancer in people with diabetes is higher for women than men, a new study finds.

Previous research identified the link between diabetes and cancer risk, but this study looked at whether that risk differs between men and women.

The takeaway: Among people with diabetes, women have a 6 percent higher risk of cancer ...

MONDAY, June 25, 2018 (HealthDay News) -- Many adult survivors of childhood cancer don't worry about their future health and may skip crucial screenings and lifestyle changes, a new study shows.

"Some of the increased health risks faced by survivors of childhood cancer can be minimized through early detection and intervention, as well as adoption of healthy behaviors," said study co-l...

MONDAY, May 7, 2018 (HealthDay News) -- Generic drugs tend to trigger big drops in the cost of their expensive, brand-name counterparts, but that has not been the case with the cancer drug commonly known as Gleevec (imatinib).

There's been only a small drop in the price of imatinib since a generic version was introduced to compete with Gleevec, a new study finds.

Gleevec is ...

FRIDAY, Dec. 15, 2017 (HealthDay News) -- A new drug that targets a genetic flaw common to most cancer cells is showing potency against many tumor types.

The preliminary trial of a drug called ulixertinib was conducted with 135 patients who had already failed treatments for one of a variety of advanced, solid tumors.

Researchers led by Dr. Ryan Sullivan, of Massachusetts Gen...

THURSDAY, Nov. 2, 2017 (HealthDay News) -- The stress of a frightening leukemia diagnosis may impede clear doctor-patient communication, a new study suggests.

Patients undergoing chemotherapy treatment for acute myeloid leukemia (AML) tend to view their illness and prognosis through a different lens from their doctors, researchers say.

Investigators found that patients are i...

THURSDAY, Oct. 19, 2017 (HealthDay News) -- The U.S. Food and Drug Administration has approved the second gene therapy for use in the United States.

The new treatment, Yescarta (axicabtagene ciloleucel), is for a kind of blood cancer called large B-cell lymphoma.

The treatment is known as chimeric antigen receptor (CAR) T cell therapy, and is only the second such therapy san...

FRIDAY, Sept. 1, 2017 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved an altered dose of the drug Mylotarg to treat a distinctive type of acute myeloid leukemia -- CD33-positive AML.

An earlier version of the drug had been withdrawn from the market when health risks started to emerge.

Known generically as gemtuzumab ozogamicin, the drug received...

WEDNESDAY, Aug. 30, 2017 (HealthDay News) -- The U.S. Food and Drug Administration broke new ground in cancer care Wednesday by approving the first gene therapy for patients in the United States.

Kymriah (tisagenlecleucel) genetically tweaks a patient's own immune system cells into what scientists call "a living drug" to battle a form of acute lymphoblastic leukemia (ALL).

T...

TUESDAY, Aug. 8, 2017 (HealthDay News) -- An antibiotic treatment intended to lower stem cell transplant patients' risk of developing a respiratory complication appears to have backfired.

French researchers explored the potential of administering the antibiotic azithromycin before and after stem cell transplantation to limit the risk for a condition known as bronchiolitis obliterans ...

WEDNESDAY, July 12, 2017 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel on Wednesday gave unanimous approval to what could soon be the first gene therapy to be marketed in the United States.

The treatment, called CTL019, genetically tweaks a patient's own immune system cells into what scientists call "a living drug" to battle a form of acute lymphoblastic leuke...

TUESDAY, June 6, 2017 (HealthDay News) -- Public-funded trials have significantly extended the lives of people diagnosed with cancer, according to new research.

SWOG, the clinical trials network funded by the U.S. National Cancer Institute (NCI), has involved more than 200,000 patient volunteers. These trials have led to approval of 14 new cancer drugs and more than 100 changes to ca...

TUESDAY, June 6, 2017 (HealthDay News) -- Cancer doctors who receive freebies from pharmaceutical companies are more likely to prescribe drugs produced by those companies, a new study reports.

Free meals, paid travel expenses and fees for consulting or lecturing appeared to influence which drugs a doctor would choose when treating two different types of cancer, said study lead researc...

MONDAY, June 5, 2017 (HealthDay News) -- The cancer drug dasatinib shows promise in treating children with chronic myeloid leukemia (CML) caused by the gene BCR-ABL, also known as the Philadelphia chromosome, researchers report.

"Despite the fact that there is a common molecular driver -- BCR-ABL -- for this disease in adults and in children, the manifestation in children is different...

FRIDAY, May 19, 2017 (HealthDay News) -- A leukemia drug might also effectively treat severe asthma, a small-scale clinical trial suggests.

Gleevec (imatinib) reduced the "twitchiness" of airways, making them less likely to reflexively constrict when exposed to an allergen or asthma trigger, said senior researcher Dr. Elliot Israel.

"We showed we could decrease the amount of...